Suppr超能文献

药物性肝损伤的动物模型。

Animal models of drug-induced liver injury.

机构信息

Dept. of Environmental and Occupational Health, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Dept. of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Dept. of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.

出版信息

Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):1031-1039. doi: 10.1016/j.bbadis.2018.08.037. Epub 2018 Sep 3.

Abstract

Drug-induced liver injury (DILI) presents unique challenges for consumers, clinicians, and regulators. It is the most common cause of acute liver failure in the US. It is also one of the most common reasons for termination of new drugs during pre-clinical testing and withdrawal of new drugs post-marketing. DILI is generally divided into two forms: intrinsic and idiosyncratic. Many of the challenges with DILI are due in large part to poor understanding of the mechanisms of toxicity. Although useful models of intrinsic DILI are available, they are frequently misused. Modeling idiosyncratic DILI presents greater challenges, but promising new models have recently been developed. The purpose of this manuscript is to provide a critical review of the most popular animal models of DILI, and to discuss the future of DILI research.

摘要

药物性肝损伤 (DILI) 给消费者、临床医生和监管机构带来了独特的挑战。它是美国急性肝衰竭的最常见原因。它也是临床前测试中终止新药和上市后撤回新药的最常见原因之一。DILI 一般分为两种形式:内在型和特发性。DILI 的许多挑战在很大程度上是由于对毒性机制的理解不佳。虽然有可用的内在型 DILI 有用模型,但它们经常被误用。特发性 DILI 的建模提出了更大的挑战,但最近已经开发出有前途的新模型。本文的目的是对最流行的 DILI 动物模型进行批判性评价,并讨论 DILI 研究的未来。

相似文献

1
Animal models of drug-induced liver injury.药物性肝损伤的动物模型。
Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):1031-1039. doi: 10.1016/j.bbadis.2018.08.037. Epub 2018 Sep 3.
3
Cell death in drug-induced liver injury.药物性肝损伤中的细胞死亡
Adv Pharmacol. 2019;85:31-74. doi: 10.1016/bs.apha.2019.01.006. Epub 2019 Feb 20.
4
Models of Idiosyncratic Drug-Induced Liver Injury.特发性药物性肝损伤模型。
Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:247-268. doi: 10.1146/annurev-pharmtox-030220-015007. Epub 2020 Sep 25.
6
Dissecting the molecular pathophysiology of drug-induced liver injury.解析药物性肝损伤的分子病理生理学。
World J Gastroenterol. 2018 Apr 7;24(13):1373-1385. doi: 10.3748/wjg.v24.i13.1373.
8
Adverse drug reactions and organ damage: The liver.药物不良反应与器官损害:肝脏
Eur J Intern Med. 2016 Mar;28:9-16. doi: 10.1016/j.ejim.2015.12.017. Epub 2016 Jan 28.

引用本文的文献

3
Advancing hepatotoxicity assessment: current advances and future directions.推进肝毒性评估:当前进展与未来方向
Toxicol Res. 2025 Apr 24;41(4):303-323. doi: 10.1007/s43188-025-00289-w. eCollection 2025 Jul.
10
Cell therapy for liver disorders: past, present and future.肝脏疾病的细胞治疗:过去、现在与未来。
Nat Rev Gastroenterol Hepatol. 2025 May;22(5):329-342. doi: 10.1038/s41575-025-01050-2. Epub 2025 Mar 18.

本文引用的文献

10
The impact of sterile inflammation in acute liver injury.无菌性炎症在急性肝损伤中的影响。
J Clin Transl Res. 2017 Feb;3(Suppl 1):170-188. doi: 10.18053/jctres.03.2017S1.003. Epub 2017 Feb 12.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验